There is not really any debate, at this point, that the HPV vaccine would prevent tens of thousands of cases of cancer a year ...

An independent panel of advisers to the Food and Drug Administration recommended the agency approve Guardant Health’s ...

An early-stage clinical trial of a radiopharmaceutical drug developed by J&J showed some signs of efficacy in prostate cancer ...

State lawmakers Thursday passed the bill to reclassify mifepristone and misoprostol, and Republican Gov. Jeff Landry is ...

Pre-game ceremonies” for ASCO, the world’s largest cancer research meeting, kick off tonight when research abstracts are ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

STAT's Rachel Cohrs Zhang discusses layoffs at BIO and Eric Boodman talks about his new investigative series on how Black ...

Everyone working in clinical trials must embrace this opportunity to re-evaluate and standardize reimbursement policies as a ...

Cytokinetics did a deal with Royalty Pharma, the biotech firm that has become a huge success by buying up small shares of ...

Three pharmaceutical industry executives donated to a a failed Senate candidate, New Jersey's first lady Tammy Murphy ...

The CDC reported rising rates of strokes among working age adults, an increase that mirrors the reversal of progress on heart ...

If Regeneron or other companies succeed in developing RNA-based obesity drugs, it would be a significant shift away from ...